$CDXS
CODEXIS, INC.

2023 Q4 Form 10-Q Financial Statement

#000120037523000033 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $26.56M $9.277M
YoY Change -12.56% -73.09%
Cost Of Revenue $2.862M $2.249M
YoY Change -66.15% -77.02%
Gross Profit $23.70M $7.028M
YoY Change 8.12% -71.53%
Gross Profit Margin 89.22% 75.76%
Selling, General & Admin $12.18M $12.30M
YoY Change -1.06% -8.87%
% of Gross Profit 51.41% 175.04%
Research & Development $11.23M $13.66M
YoY Change -42.94% -37.39%
% of Gross Profit 47.4% 194.39%
Depreciation & Amortization $1.216M $1.357M
YoY Change -16.66% -3.42%
% of Gross Profit 5.13% 19.31%
Operating Expenses $23.42M $25.96M
YoY Change -26.83% -26.49%
Operating Profit $281.0K -$32.06M
YoY Change -102.79% 201.43%
Interest Expense $906.0K $1.060M
YoY Change 10.09% 143.12%
% of Operating Profit 322.42%
Other Income/Expense, Net -$8.344M -$3.895M
YoY Change 31992.31% -1903.24%
Pretax Income -$7.157M -$34.90M
YoY Change -42.53% 249.55%
Income Tax $35.00K $9.000K
% Of Pretax Income
Net Earnings -$7.192M -$34.91M
YoY Change -42.94% 249.36%
Net Earnings / Revenue -27.08% -376.29%
Basic Earnings Per Share -$0.50
Diluted Earnings Per Share -$0.10 -$0.50
COMMON SHARES
Basic Shares Outstanding 69.83M shares 69.80M shares
Diluted Shares Outstanding 69.47M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.12M $74.60M
YoY Change -42.87% -31.36%
Cash & Equivalents $65.10M $74.60M
Short-Term Investments
Other Short-Term Assets $600.0K $7.000M
YoY Change -90.01% 18.44%
Inventory $2.685M $2.305M
Prepaid Expenses $4.600M
Receivables $10.04M $19.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $93.47M $103.0M
YoY Change -42.62% -29.44%
LONG-TERM ASSETS
Property, Plant & Equipment $15.49M $15.28M
YoY Change -31.52% -34.47%
Goodwill $2.463M $2.463M
YoY Change -23.03% -23.03%
Intangibles
YoY Change
Long-Term Investments $9.700M $18.00M
YoY Change -52.71% -12.24%
Other Assets $1.246M $726.0K
YoY Change 256.0% 249.04%
Total Long-Term Assets $43.10M $51.44M
YoY Change -50.75% -42.39%
TOTAL ASSETS
Total Short-Term Assets $93.47M $103.0M
Total Long-Term Assets $43.10M $51.44M
Total Assets $136.6M $154.5M
YoY Change -45.46% -34.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.947M $3.098M
YoY Change 83.21% 18.2%
Accrued Expenses $4.735M $8.796M
YoY Change -69.01% -32.3%
Deferred Revenue $3.781M $9.236M
YoY Change -72.46% 476.53%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.83M $38.42M
YoY Change -26.98% 20.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.233M $1.219M
YoY Change -10.07% -10.1%
Total Long-Term Liabilities $1.233M $1.219M
YoY Change -10.07% -10.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.83M $38.42M
Total Long-Term Liabilities $1.233M $1.219M
Total Liabilities $49.95M $62.95M
YoY Change -52.7% -22.44%
SHAREHOLDERS EQUITY
Retained Earnings -$497.5M -$490.3M
YoY Change 18.1% 19.98%
Common Stock $7.000K $6.000K
YoY Change 16.67% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $86.62M $91.51M
YoY Change
Total Liabilities & Shareholders Equity $136.6M $154.5M
YoY Change -45.46% -34.35%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$7.192M -$34.91M
YoY Change -42.94% 249.36%
Depreciation, Depletion And Amortization $1.216M $1.357M
YoY Change -16.66% -3.42%
Cash From Operating Activities -$11.04M -$16.30M
YoY Change -324.47% -182.6%
INVESTING ACTIVITIES
Capital Expenditures -$380.0K $680.0K
YoY Change 1051.52% -151.91%
Acquisitions
YoY Change
Other Investing Activities $724.0K -$420.0K
YoY Change -42100.0%
Cash From Investing Activities $1.104M -$1.100M
YoY Change 3245.45% -15.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000K -110.0K
YoY Change -100.88% -182.71%
NET CHANGE
Cash From Operating Activities -11.04M -16.30M
Cash From Investing Activities 1.104M -1.100M
Cash From Financing Activities -3.000K -110.0K
Net Change In Cash -9.933M -17.51M
YoY Change -287.8% -194.35%
FREE CASH FLOW
Cash From Operating Activities -$11.04M -$16.30M
Capital Expenditures -$380.0K $680.0K
Free Cash Flow -$10.66M -$16.98M
YoY Change -315.29% -180.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
1936000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
2116000 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
5661000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7016000 usd
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
19226000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
41036000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5487000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34470000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2249000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9786000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69466000 shares
us-gaap Depreciation
Depreciation
3961000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3618000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-307000 usd
us-gaap Other Noncash Income
OtherNoncashIncome
1245000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11629000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
31904000 usd
CY2023Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
133000 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
163000 usd
CY2023Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
19093000 usd
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
40873000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2305000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2029000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5402000 usd
CY2023Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
646000 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2023Q3 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
18013000 usd
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
20510000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13895000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39263000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15282000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22614000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2463000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3241000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
726000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
350000 usd
CY2023Q3 us-gaap Assets
Assets
154455000 usd
CY2022Q4 us-gaap Assets
Assets
250393000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3098000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3246000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10521000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11453000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8796000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15279000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6764000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5360000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9236000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13728000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
38415000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49066000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10100000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
16881000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13215000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38278000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-490338000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-421290000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91506000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
144797000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154455000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250393000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9277000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43582000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13662000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39859000 usd
us-gaap Restructuring Charges
RestructuringCharges
3284000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q3 cdxs Asset Impairment And Other Charges
AssetImpairmentAndOtherCharges
0 usd
cdxs Asset Impairment And Other Charges
AssetImpairmentAndOtherCharges
9984000 usd
cdxs Asset Impairment And Other Charges
AssetImpairmentAndOtherCharges
0 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
41337000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
45106000 usd
us-gaap Costs And Expenses
CostsAndExpenses
111932000 usd
us-gaap Costs And Expenses
CostsAndExpenses
129846000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32060000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10636000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-68350000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21631000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1056000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
436000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3266000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
618000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3895000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
216000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3930000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34899000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9984000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69014000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20863000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-34908000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9992000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69048000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20988000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69466000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65426000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65426000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67670000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67670000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65271000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65271000 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
124131000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2283000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-34908000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91506000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
159459000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4516000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
15000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
47000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9992000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
154131000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
144797000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
422000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7808000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
721000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7931000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
404000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69048000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91506000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
164391000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
612000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11467000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
133000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1484000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69048000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20988000 usd
us-gaap Depreciation
Depreciation
4302000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3647000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7808000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11600000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Other Noncash Income
OtherNoncashIncome
187000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
208000 usd
cdxs Asset Impairment And Other Charges
AssetImpairmentAndOtherCharges
9984000 usd
cdxs Asset Impairment And Other Charges
AssetImpairmentAndOtherCharges
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3875000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-29000 usd
us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-21580000 usd
us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-8184000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
276000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
463000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
252000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-429000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-105000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-351000 usd
cdxs Increase Decrease In Employee Related Liabilities And Other Accrued Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilitiesAndOtherAccruedLiabilities
7269000 usd
cdxs Increase Decrease In Employee Related Liabilities And Other Accrued Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilitiesAndOtherAccruedLiabilities
-2279000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4384000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3863000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11273000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3750000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41601000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6367000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4798000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8340000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
27000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1191000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13611000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
503000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
404000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1484000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8167000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-914000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39396000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8158000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116026000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118895000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76630000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110737000 usd
us-gaap Interest Paid Net
InterestPaidNet
28000 usd
us-gaap Interest Paid Net
InterestPaidNet
22000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
193000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
100000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
159000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
128000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74577000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108689000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2053000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2048000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76630000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110737000 usd
us-gaap Nature Of Operations
NatureOfOperations
Description of Business<div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In these notes to the unaudited condensed consolidated financial statements, the “Company,” “we,” “us,” and “our” refers to Codexis, Inc. and its subsidiaries on a consolidated basis.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins leveraging our proprietary CodeEvolver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directed evolution platform.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2023, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we reported our financial results based on two reportable segments: Performance Enzymes and Novel Biotherapeutics. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Performance Enzymes business consists primarily of two focus areas: i) biocatalysts for the enzymatic manufacturing of pharmaceuticals and ii) enzymes for life science applications, including genomic sequencing and nucleic acid synthesis. Our Novel Biotherapeutics business includes product candidates in clinical and preclinical development. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment information aligns with how the chief operating decision maker (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CODM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), who is our Chief Executive Officer (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), reviews and manages the business. In July 2023, we announced a restructuring of our business and that we are discontinuing investment in certain development programs, primarily in Novel Biotherapeutics.</span></div>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. We regularly assess these estimates which primarily affect revenue recognition, deferred revenue, inventories, valuation of equity investments, valuation of assets held for sale, goodwill arising out of business acquisitions, accrued liabilities, stock awards, and the valuation allowances associated with deferred tax assets. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements.</span></div>
cdxs Contractwith Customer Liability New Activities Performance Obligation Satisfied Revenue Recognition
ContractwithCustomerLiabilityNewActivitiesPerformanceObligationSatisfiedRevenueRecognition
106156000 usd
CY2023Q3 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
9277000 usd
CY2022Q3 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
34470000 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
43582000 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
108215000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9277000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34470000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9277000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9277000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34470000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34470000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43582000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43582000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108215000 usd
CY2023Q3 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
1936000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
2116000 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
5661000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7016000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
0 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19336000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30609000 usd
CY2022Q3 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0 usd
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0 usd
CY2023Q3 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0 usd
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0 usd
CY2023Q2 cdxs Contract With Customer Liability Release Early Termination Of Obligation
ContractWithCustomerLiabilityReleaseEarlyTerminationOfObligation
2900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1303000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
889000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9111000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1694000 usd
CY2023Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
1018000 usd
CY2022Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
495000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
4238000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
365000 usd
CY2023Q3 cdxs Contractwith Customer Liability New Activities Performance Obligation Satisfied Revenue Recognition
ContractwithCustomerLiabilityNewActivitiesPerformanceObligationSatisfiedRevenueRecognition
6956000 usd
CY2022Q3 cdxs Contractwith Customer Liability New Activities Performance Obligation Satisfied Revenue Recognition
ContractwithCustomerLiabilityNewActivitiesPerformanceObligationSatisfiedRevenueRecognition
33086000 usd
cdxs Contractwith Customer Liability New Activities Performance Obligation Satisfied Revenue Recognition
ContractwithCustomerLiabilityNewActivitiesPerformanceObligationSatisfiedRevenueRecognition
30233000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9106000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9590000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
140000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
500000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
19336000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3900000 usd
CY2023Q3 cdxs Non Marketable Debt Securities Without Readily Determinable Fair Value Annual Amount
NonMarketableDebtSecuritiesWithoutReadilyDeterminableFairValueAnnualAmount
0 usd
cdxs Non Marketable Debt Securities Without Readily Determinable Fair Value Annual Amount
NonMarketableDebtSecuritiesWithoutReadilyDeterminableFairValueAnnualAmount
0 usd
cdxs Non Marketable Debt Securities Without Readily Determinable Fair Value Annual Amount
NonMarketableDebtSecuritiesWithoutReadilyDeterminableFairValueAnnualAmount
0 usd
CY2022Q3 cdxs Non Marketable Debt Securities Without Readily Determinable Fair Value Annual Amount
NonMarketableDebtSecuritiesWithoutReadilyDeterminableFairValueAnnualAmount
0 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
18013000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
20510000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39821000 usd
CY2023Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
600000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74600000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114000000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
108000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
108000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
91000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2197000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1830000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2305000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2029000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1400000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1400000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54369000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62435000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39087000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15282000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22614000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1500000 usd
CY2023Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
600000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1357000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1405000 usd
us-gaap Depreciation
Depreciation
4302000 usd
us-gaap Depreciation
Depreciation
3961000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3241000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
778000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2463000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
800000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
800000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3200000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
5149000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
3495000 usd
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
2644000 usd
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
10852000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1003000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
932000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8796000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15279000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2283000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4531000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7808000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11600000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
43638000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5668000 usd
cdxs Operating Lease Interest Accretion
OperatingLeaseInterestAccretion
1631000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2283000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4531000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7808000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11600000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
214284 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
252100 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.43
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000 usd
CY2023Q1 cdxs Sale Of Stock Securities Registered Aggregate Amount
SaleOfStockSecuritiesRegisteredAggregateAmount
200000000 usd
cdxs Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
8700000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
7900000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700000 usd
CY2023Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
77300 sqft
CY2023Q3 cdxs Lessee Operating Lease Option To Extend Number
LesseeOperatingLeaseOptionToExtendNumber
1 option
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39263000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3647000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
898000 usd
cdxs Operating Lease Write Off Due To Lease Modification
OperatingLeaseWriteOffDueToLeaseModification
19622000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2997000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13895000 usd
cdxs Operating Lease Write Off Due To Lease Modification
OperatingLeaseWriteOffDueToLeaseModification
19622000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19979000 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
300000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
500000 usd
CY2023Q3 cdxs Finance Lease Cost
FinanceLeaseCost
0 usd
CY2022Q3 cdxs Finance Lease Cost
FinanceLeaseCost
0 usd
cdxs Finance Lease Cost
FinanceLeaseCost
0 usd
cdxs Finance Lease Cost
FinanceLeaseCost
18000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1618000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1831000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
5278000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
5491000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
40000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
1618000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
1831000 usd
us-gaap Lease Cost
LeaseCost
5278000 usd
us-gaap Lease Cost
LeaseCost
5549000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
us-gaap Operating Lease Payments
OperatingLeasePayments
5668000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4658000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4229000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4727000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4868000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5014000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2533000 usd
CY2023Q3 cdxs Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1078000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22449000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2470000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19979000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6764000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13215000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19979000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34899000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9984000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69014000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20863000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
800000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
800000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9277000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34470000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43582000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108215000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3241000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
778000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2463000 usd
CY2023Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
133000 usd
CY2022Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
109000 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
163000 usd
CY2021Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
416000 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2023Q3 cdxs Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
0 usd
CY2022Q3 cdxs Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
0 usd
cdxs Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
-30000 usd
cdxs Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
-257000 usd
CY2023Q3 cdxs Allowance For Credit Loss Adjustment
AllowanceForCreditLossAdjustment
0 usd
CY2022Q3 cdxs Allowance For Credit Loss Adjustment
AllowanceForCreditLossAdjustment
0 usd
cdxs Allowance For Credit Loss Adjustment
AllowanceForCreditLossAdjustment
0 usd
cdxs Allowance For Credit Loss Adjustment
AllowanceForCreditLossAdjustment
-50000 usd
CY2023Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
133000 usd
CY2022Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
109000 usd
CY2023Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
133000 usd
CY2022Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
109000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11629000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
31904000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1500000 usd
CY2023Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
600000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
R24.htm Edgar Link pending
0001200375-23-000033-index-headers.html Edgar Link pending
0001200375-23-000033-index.html Edgar Link pending
0001200375-23-000033.txt Edgar Link pending
0001200375-23-000033-xbrl.zip Edgar Link pending
cdxs-20230930.htm Edgar Link pending
cdxs-20230930.xsd Edgar Link pending
cdxs_20230930xex311.htm Edgar Link pending
cdxs_20230930xex312.htm Edgar Link pending
cdxs_20230930xex321.htm Edgar Link pending
codexis-ex101codexis_vaxcy.htm Edgar Link pending
codexis-ex102landlordconse.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
cdxs-20230930_cal.xml Edgar Link unprocessable
cdxs-20230930_def.xml Edgar Link unprocessable
cdxs-20230930_lab.xml Edgar Link unprocessable
cdxs-20230930_pre.xml Edgar Link unprocessable
cdxs-20230930_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable